Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spero Therapeutics Inc 675 Massachusetts Avenue 14th Floor Cambridge MA 02139 USA

https://sperotherapeutics.com Employees: 32 P: 857-242-1600

Sector:

Medical

Description:

Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.

Key Statistics

Overview:

Market Capitalization, $K 130,706
Enterprise Value, $K 77,816
Shares Outstanding, K 56,339
Annual Sales, $ 47,980 K
Annual Net Income, $ -68,570 K
Last Quarter Sales, $ 5,440 K
Last Quarter Net Income, $ -7,380 K
EBIT, $ -45,940 K
EBITDA, $ -45,570 K
60-Month Beta 1.48
% of Insider Shareholders 5.50%
% of Institutional Shareholders 25.60%
Float, K 53,240
% Float 94.50%
Short Interest 1,056
Short Float 1.87%
Short Volume Ratio 0.23

Growth:

1-Year Return 122.33%
3-Year Return 34.10%
5-Year Return -88.04%
5-Year Revenue Growth 164.35%
5-Year Earnings Growth 62.09%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -0.79
EPS Growth vs. Prev Qtr -333.33%
EPS Growth vs. Prev Year 59.38%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 09/16/15
Dividend Payout Ratio 0.00%

SPRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -125.91%
Return-on-Assets % -57.58%
Profit Margin % -142.91%
Debt/Equity 0.00
Price/Sales 2.75
Price/Cash Flow N/A
Price/Book 4.97
Book Value/Share 0.47
Interest Coverage -1.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar